Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Clinical and Experimental Gastroenterology|July 15, 2011
Enzyme replacement therapy for pancreatic insufficiency: present and futureAaron Fieker, Jessica Philpott, Martine ArmandCleveland Clinic Journal of Medicine|August 29, 2020
COVID-19 in patients with IBD and pancreaticobiliary disordersSara El Ouali, Jessica Philpott, John Vargo, et al.Gastroenterology Report|April 13, 2019
Vedolizumab for chronic antibiotic-refractory pouchitisAmandeep Singh, Freeha Khan, Rocio Lopez, et al.Journal for Immunotherapy of Cancer|June 23, 2021
Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective studyJoseph Sleiman, Wei Wei, Ravi Shah, et al.Journal of Crohn'S & Colitis|December 18, 2014
Risk factors for Crohn’s disease of the neo-small intestine in ulcerative colitis patients with total proctocolectomy and primary or secondary ileostomiesPeng Du, Chao Sun, Jean Ashburn, et al.Inorganic Chemistry|November 16, 2012
Hetero-multinuclear ruthenium(III)/platinum(II) complexes that potentially exhibit both antimetastatic and antineoplastic propertiesCraig M Anderson, Isabelle R Taylor, Michael F Tibbetts, et al.Digestive Diseases and Sciences|September 14, 2016
Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel DiseasesNicholas Horton, Xianrui Wu, Jessica Philpott, et al.Journal of Crohn'S & Colitis|September 9, 2017
Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn's Disease-associated Strictures-A Cohort StudyAmandeep Singh, Neha Agrawal, Satya Kurada, et al.Digestive Diseases and Sciences|May 11, 2026
Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched AnalysisRidhima Kaul, Renan Prado, Arjun Chatterjee, et al.Digestive Diseases and Sciences|June 23, 2021
Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease PatientsRajat Garg, Manik Aggarwal, Robert Butler, et al.Pageof 3